How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →

Biotheryx to Present Results from its Phase 1A Dose Escalation Study of BTX-9341 for the Treatment of HR+/HER2- Breast Cancer at the 2026 European Society for Medical Oncology Breast Cancer Annual Congress

calendar_today May 4, 2026 person biotheryx domain biotheryx

SAN DIEGO, CA, May 4, 2026 – Biotheryx, Inc., a biopharmaceutical company focused on the discovery and development of first-in-class[…] Read More